BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 29887143)

  • 1. Prion-like propagation of pathology in Parkinson disease.
    Volpicelli-Daley L; Brundin P
    Handb Clin Neurol; 2018; 153():321-335. PubMed ID: 29887143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spreading of alpha-synuclein - relevant or epiphenomenon?
    Killinger BA; Kordower JH
    J Neurochem; 2019 Sep; 150(5):605-611. PubMed ID: 31152606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
    Dunning CJ; George S; Brundin P
    Prion; 2013; 7(1):92-7. PubMed ID: 23360753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
    Masuda-Suzukake M; Hasegawa M
    Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concept of alpha-synuclein as a prion-like protein: ten years after.
    Steiner JA; Quansah E; Brundin P
    Cell Tissue Res; 2018 Jul; 373(1):161-173. PubMed ID: 29480459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prion Properties of Alpha-Synuclein].
    Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
    Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.
    Tarutani A; Suzuki G; Shimozawa A; Nonaka T; Akiyama H; Hisanaga S; Hasegawa M
    J Biol Chem; 2016 Sep; 291(36):18675-88. PubMed ID: 27382062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Uchihara T; Giasson BI
    Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease from the gut.
    Liddle RA
    Brain Res; 2018 Aug; 1693(Pt B):201-206. PubMed ID: 29360467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Lewy pathology propagation in Parkinson's disease.
    Luk KC; Lee VM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology.
    Li X; Koudstaal W; Fletcher L; Costa M; van Winsen M; Siregar B; Inganäs H; Kim J; Keogh E; Macedo J; Holland T; Perry S; Bard F; Hoozemans JJ; Goudsmit J; Apetri A; Pascual G
    Acta Neuropathol; 2019 May; 137(5):825-836. PubMed ID: 30805666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns.
    Rahayel S; Mišić B; Zheng YQ; Liu ZQ; Abdelgawad A; Abbasi N; Caputo A; Zhang B; Lo A; Kehm V; Kozak M; Yoo HS; Dagher A; Luk KC
    Brain; 2022 Jun; 145(5):1743-1756. PubMed ID: 34910119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.
    Tyson T; Steiner JA; Brundin P
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):275-289. PubMed ID: 26617280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.